Rumin8

About Rumin8

Rumin8, a climate technology firm based in Perth, Australia, was founded in 2021 by David Messina and Dr Stewart Washer to address the significant challenge of methane emissions from livestock. Mr. Messina, the CEO, brings a wealth of experience from his background on a farm in Western Australia and executive roles in agriculture, energy, and biotech startups. This foundation provides him with a deep understanding of the agricultural sector's challenges and opportunities. The company's core idea stemmed from a conversation between the founders about synthetically manufacturing the active anti-methane compounds found in nature, such as in Asparagopsis seaweed, to create a more scalable and cost-effective solution than cultivating the seaweed itself.

The company operates in the AgTech and CleanTech sectors, targeting the global livestock industry, including beef and dairy producers. Rumin8's business model revolves around the development and commercialization of feed and water additives that reduce enteric methane production in ruminant animals. The core of its product is synthetically reproduced tribromomethane (bromoform), a bioactive compound found in red seaweed. By using a pharmaceutical approach, the company can manufacture and stabilize this compound efficiently, ensuring quality and consistency. The technology is designed to interrupt the enzymatic pathway that creates methane during digestion, allowing the animal to redirect that energy, which can lead to productivity gains such as increased weight. Rumin8 is developing multiple formulations—including liquid, powder, and granular forms—to suit various farming systems, from feedlots to pasture-based grazing.

Rumin8 has made significant progress, backed by substantial funding and promising trial results. The company has raised approximately $17.4 million through several funding rounds, attracting high-profile investors like Bill Gates-founded Breakthrough Energy Ventures, Prelude Ventures, and Harvest Road Group. This capital is being used to fund extensive commercial trials in key markets such as Australia, New Zealand, Brazil, and the US, and to develop a pilot manufacturing plant. Scientific studies, including a peer-reviewed trial at UC Davis, have validated the product's effectiveness, showing methane emission reductions of up to 95% in feedlot cattle, without negatively impacting animal health. The company has received provisional regulatory approval in Brazil and New Zealand to conduct further trials required for full commercialization. With the opening of a demonstration plant in Wangara in early 2024, Rumin8 is advancing its capacity for large-scale production.